| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $67K | — | +179.4% |
| SG&A Expense | $496K | — | +60.5% |
| Operating Income | -$826K | — | -42.2% |
| Pre-tax Income | -$943K | — | -57.1% |
| Net Income | -$943K | — | -57.1% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.9M | +61.5% | +628.2% |
| Inventory | $74K | +155.6% | +979.4% |
| Current Assets | $3.0M | +61.1% | +565.0% |
| Total Assets | $3.7M | +45.1% | +182.8% |
| Current Liabilities | $10.7M | +2.2% | +8.7% |
| Total Liabilities | $10.8M | +2.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$530K | — | -21.9% |
| Capital Expenditures | $14K | — | — |
| Investing Cash Flow | -$14K | — | — |
| Financing Cash Flow | $1.6M | — | +939.3% |
| Free Cash Flow | -$544K | — | — |
| +9.3% |
| Stockholders' Equity | -$7.1M | +11.7% | +17.4% |